Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Year: 2016
Type: letter
Source: New England Journal of Medicine
DOI: 10.1056/nejmc1600827
Authors: Pantelis A Sarafidis, Apostolos Tsapas
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2297835124
